// App-Quantinova.ai

: Cardiovascular Risks of Chemo-Immunotherapy for Lung Cancer A Population-Based Cohort Study

Researchers

Presenter

  • Jeffrey S Chan

Principal Investigators

  • Hoi Kiu Pias Tang

  • Kenrick Ng

  • Edward Christopher Dee

  • Teddy Lee

  • Oscar Hou In Chou

  • Yan Hiu Athena Lee

  • Dawnie Ho Hei Lau

  • Tong Liu

  • Gary Tse

Medical Centers

  • Cardio-Oncology Rsch Unit, Cardiovascular Analytics Group, Hong Kong

  • Kent and Medway Med Sch, United Kingdom

  • Dept of Med Oncology, Univ College London Hosps NHS Foundation Trust, London, United Kingdom

  • 2nd Hosp of Tianjin Med Univ, Tianjin, China

  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

Locations

  • United Kingdom

  • China

  • Hong Kong

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Congestive heart failure

  • Lung Cancer

  • Solid malignancies

  • Stroke

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved